Precision medicine and the expanding perioperative role by Anaesthesiologists

Abstract

In the rapidly evolving healthcare landscape, precision medicine is emerging as a transformative approach that seeks to individualise patient care based on genetic, environmental, and lifestyle factors. This paradigm shift aligns seamlessly with the perioperative scope of anaesthesiology, where tailoring anaesthetic management to individual patient profiles can significantly improve outcomes, reduce complications, and enhance recovery. Anaesthesiologists are uniquely positioned to lead and integrate precision medicine across the perioperative continuum—from preoperative risk stratification to intraoperative decision-making and postoperative care.[1] DEFINING PRECISION MEDICINE IN THE PERIOPERATIVE CONTEXT As articulated by Collins and Varmus,[2] precision medicine is an approach to disease treatment and prevention that considers individual variability in genes, environment, and lifestyle. In the perioperative realm, this translates to using biomarkers, pharmacogenomics, and data-driven analytics to guide anaesthetic techniques, drug dosing, and perioperative monitoring. Anaesthesiologists can now access tools and knowledge to integrate patient-specific genomic and metabolic profiles. For example, genetic testing for CYP2D6 polymorphisms influences opioid metabolism, directly impacting analgesic efficacy and safety.[3] Similarly, pharmacogenomic considerations help predict susceptibility to opioid use disorders, supporting safer prescribing practices.[4] APPLICATIONS IN CLINICAL ANAESTHESIA Recent developments in the use of big data and machine learning have provided new opportunities for perioperative precision medicine. For example, predictive analytics platforms integrated with electronic health records may help identify patients at increased genetic risk for conditions such as malignant hyperthermia.[5] By screening for RYR1 or CACNA1S gene variants and cross-referencing prior anaesthetic exposure and family history, anaesthesiologists can take preventive steps, such as avoiding known triggering agents and ensuring dantrolene availability in advance. This approach can significantly enhance patient safety and personalise anaesthetic planning based on genetic predispositions, as highlighted in recent discussions in the ASA Monitor. In a 2024 article, Mathis and colleagues[6] outline a practical framework for leveraging predictive analytics to enhance perioperative quality improvement and patient safety. Based on the Multicentre Perioperative Outcomes Group (MPOG) guidelines, their work demonstrates how anaesthesiologists can utilise real-time clinical data and modelling to stratify risk, personalised care, and proactively manage intraoperative and postoperative complications. The application of precision medicine in anaesthesiology continues to expand in several key domains: Pharmacogenomics: Tailoring medication regimens based on genotypic variation helps avoid adverse drug events and optimise dosing. This is especially relevant for commonly used anaesthetics and analgesics metabolised by polymorphic enzymes.[7] Clinical Implementation: Large collaborative networks have demonstrated successful clinical integration of pharmacogenetics across healthcare systems, improving safety and standardisation.[8] Personalised Pain Management: Tools such as the Opioid Risk Tool, combined with genomic insight, provide anaesthesiologists with a predictive framework to reduce opioid-related complications.[3] Data-Driven Practice: The rise of big data, machine learning, and real-time EHR integration enables anaesthesiologists to refine decision-making and anticipate risks more accurately.[9] As outlined earlier, a notable recent publication by Mathis et al. presents a framework for utilising big data and machine learning to improve perioperative quality, research, and safety outcomes. The article highlights the work of the MPOG and the strategic application of predictive modelling in anaesthesia. Enhanced Recovery Pathways: Enhanced Recovery After Surgery protocols exemplify the structured, multidisciplinary use of evidence-based strategies that can be further individualised through precision interventions.[10] EXPANDING THE ROLE OF THE ANAESTHESIOLOGIST The evolving integration of genomic and biomarker data empowers anaesthesiologists to function as perioperative systems-based leaders. Their diverse skill set, encompassing critical care, procedural expertise, and real-time physiological monitoring, positions anaesthesiologists as ideal champions for implementing precision medicine at the institutional level.[11] Anaesthesiologists are also at the forefront of clinical informatics and quality improvement, translating emerging scientific insights into pragmatic clinical workflows. This includes real-time risk modelling, phenotype prediction, and response-to-therapy assessments. CHALLENGES AND OPPORTUNITIES Despite the strong potential, barriers remain in the widespread adoption of precision medicine in anaesthesiology: Workforce Training: Current anaesthesia education includes minimal content on genomics or bioinformatics.[12] Data Integration: Most EHR systems are not designed to ingest and act on genomics or pharmacogenetic data in real time.[9] Standardisation and Equity: Standardised implementation protocols and efforts to ensure equitable access to testing remain underdeveloped.[8] However, as evidence and infrastructure evolve, anaesthesiologists can leverage these tools to lead safer, more cost-effective, and patient-centred perioperative care. CONCLUSION Precision medicine offers a compelling framework for anaesthesiologists to elevate perioperative care into a truly individualised, predictive science. Anaesthesiologists can improve surgical outcomes and reduce risk by incorporating pharmacogenomics, real-time analytics, and molecular diagnostics into their routine practice. Importantly, they reaffirm their role as proceduralists and integrative perioperative physicians advancing the frontiers of personalised medicine.

Topics & Concepts